FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3092573 · Received May 3, 2013

Report

Report Number
2124215-2013-06097
Event Type
Malfunction
Date Received
May 3, 2013
Date of Event
March 6, 2013
Report Date
April 11, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THE DEVICE HAD NO TELEMETRY CONDITION THAT WAS NOTED UPON ARRIVAL AT BSC WAS THE RESULT OF A FULLY DEPLETED BATTERY. ONCE THE BATTERY WAS REMOVED FROM THE CIRCUIT THE DEVICE CURRENT WAS NORMAL AND PASSED ALL TESTING. AFTER EXHAUSTIVE ANALYSIS ON THE DEPLETED CELL THE CAUSE OF THE BATTERY DEPLETION COULD NOT BE DETERMINED.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, INITIAL TESTING CONFIRMED THE DEVICE TO EXHIBIT NO TELEMETRY. ANALYSIS OF THE RETURNED PRODUCT IS CURRENTLY ONGOING. THIS EVENT WILL BE UPDATED UPON COMPLETION OF THE ANALYSIS.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE WAS RETURNED FOR RELIABILITY ANALYSIS. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
194882 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E102

Patients

Seq Age Sex Outcome Treatment
1 50 YR 0184| E102